Xinde Chen
6Patents
1h-index
17Co-inventors
37Inventor score
Filing activity: Dec 28, 2015 → May 8, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11117899B2 | [1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor | Human Necessities | 2 | Active |
| US10280146B2 | Pyrimidone compounds used as Lp-PLA2 inhibitors and pharmaceutical compositions thereof | Chemistry; Metallurgy | 1 | Active |
| US10787422B2 | Pyrimidone compounds used as Lp-PLA2 inhibitors and pharmaceutical compositions thereof | Chemistry; Metallurgy | 0 | Active |
| US11066411B2 | [1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitor | General | 0 | Revoked |
| US11649239B2 | Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)methanol (compound 1) | Chemistry; Metallurgy | 0 | Active |
| US12030897B2 | Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and application thereof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.